Fact CheckerSign in

NCT06077604Completed

Influence of Air Pollution on SPondyloarthritis Flare-ups and Resistance to Treatment

Source: ClinicalTrials.gov · Last updated 9 Jul 2025

Brief summary (registry, in English)

The relationship between exposure to air pollution and spondyloarthritis (SpA) has been poorly studied. Based on data from the literature on other inflammatory pathologies such as rheumatoid arthritis, we hypothesize that there is a relationship between exposure to air pollution and the risk of presenting a flare-up in SpA patients following and living in Franche-Comté (France). Primary objective:The potential relationship between exposure to air pollution (nitrogen dioxide, fine particles with a diameter of less than 10 or 2.5 microns and Ozone) and the onset of a spondyloarthritis flare-up will be explored in patients with this pathology.

Status (registry)
Completed
Study type
Observational
Enrollment
182 (actual)
First submitted
5 Oct 2023
Start date
Mar 2024
Primary completion date
Oct 2024
Lead sponsor
Centre Hospitalier Universitaire de Besancon
NCT number
NCT06077604

What you commit to

  • Study type: Observational
  • Participants enrolled: 182
  • From Mar 2024 to the primary completion date, Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • No inflammatory rheumatic disease

Other

  • Other chronic inflammatory rheumatism (rheumatoid arthritis according to ACR 2010 criteria or psoriatic arthritis according to ClASsification criteria for Psoriatic ARthritis criteria)

Who the study is looking for

  • Diagnosis of Axial Spondyloarthritis (radiographic or non-radiographic) according to Assessment of SpondyloArthritis international Society (ASAS) criteria
  • Patient having received a consultation / hospitalization during the period 2019-2022
  • Patient enrolled in the MISTIC cohort
  • Having lived in Franche-Comté during the 2019-2022 period.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Besançon University Hospital
Coordinator of this site? Confirm its status
BesançonFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.